Outcomes of atypical spitz tumors with chromosomal copy number aberrations and conventional melanomas in children

American Journal of Surgical Pathology

Volumn 37, Issue 9, 2013, Pages 1387-1394

  Gerami, Pedram ^a   Cooper, Chelsea ^a   Bajaj, Shirin ^a   Wagner, Annette ^b   Fullen, Douglas ^d   Busam, Klaus ^e   Scolyer, Richard A ^j   Xu, Xiaowei ^f   Elder, David E ^f   Abraham, Ronnie M ^f   Prieto, Victor G ^g,h   Guitart, Joan ^a   Liu, Ping ^c   Pestova, Ekaterina ^c   Barnhill, Raymond L ⁱ  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Abbott Molecular Inc   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h University of Texas Health Science Center at Houston   (United States)

ⁱ UCLA MEDICAL CENTER   (United States)

^j ROYAL PRINCE ALFRED HOSPITAL   (Australia)

more..

Author keywords

Atypical Spitz tumors; Melanoma; Pediatric melanoma; Spitz nevi; Spitzoid melanoma

Indexed keywords

ADOLESCENT; AGE; ARTICLE; AUSTRALIA; CHILD; CHROMOSOME ABERRATION; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION; GENETICS; HUMAN; HUMAN CHROMOSOME; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEVUS; PATHOLOGY; PHENOTYPE; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR; SKIN TUMOR; STATISTICAL MODEL; UNITED STATES;

ADOLESCENT; AGE FACTORS; AUSTRALIA; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MELANOMA; MULTIVARIATE ANALYSIS; NEVUS, EPITHELIOID AND SPINDLE CELL; PHENOTYPE; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS; UNITED STATES;

EID: 84884527696     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31828fc283     Document Type: Article

References (33)

1. Lewis KG. Trends in pediatric melanoma mortality in the United States, 1968 through 2004. Dermatol Surg. 2008;34:152-159.
2. Hill SJ, Delman KA. Pediatric melanomas and the atypical spitzoid melanocytic neoplasms. Am J Surg. 2012;203:761-767.
3. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30:513-520.
4. Dahlstrom JE, Scolyer RA, Thompson JF, et al. Spitz naevus: diagnostic problems and their management implications. Pathology. 2004;36:452-457.
5. Cerroni L, Kerl H. Tutorial on melanocytic lesions. Am J Dermatopathol. 2001;23:237-241.
6. Berk DR, LaBuz E, Dadras SS, et al. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults-the Stanford experience 1995-2008. Pediatr Dermatol. 2010;27:244-254.
7. Elder DE, Xu X. The approach to the patient with a difficult melanocytic lesion. Pathology. 2004;36:428-434.
8. Ludgate MW, Fullen DR, Lee J, et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2009;115:631-641.
9. Mones JM, Ackerman AB. Atypical Spitz's nevus, malignant Spitz's nevus, and metastasizing Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol. 2004;26:310-333.
10. Mooi WJ, Krausz T. Spitz nevus versus spitzoid melanoma: diagnostic difficulties, conceptual controversies. Adv Anat Pathol. 2006;13:147-156.
11. Raskin L, Ludgate M, Iyer RK, et al. Copy number variations and clinical outcome in atypical Spitz tumors. Am J Surg Pathol. 2011;35:243-252.
12. Lohmann CM, Coit DG, Brady MS, et al. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol. 2002;26:47-55.
13. Busam KJ, Murali R, Pulitzer M, et al. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol. 2009;33:1386-1395.
14. Aldrink JH, Selim MA, Diesen DL, et al. Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg. 2009;44:1514-1521.
15. Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol. 2008;5:18-23.
16. Su LD, Fullen DR, Sondak VK, et al. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer. 2003;97:499-507.
17. Gerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013. doi: 10. 1097/PAS. 0b013e3182753de6.
18. Han D, Zager JS, Han G, et al. The unique clinical characteristics of melanoma diagnosed in children. Ann Surg Oncol. 2012;19: 3888-3895.
19. Neier M, Pappo A, Navid F. Management of melanomas in children and young adults. J Pediatr Hematol Oncol. 2012;34(suppl 2): S51-S54.
20. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115:649-654.
21. Mones JM, Ackerman AB. Melanomas in prepubescent children: review comprehensively, critique historically, criteria diagnostically, and course biologically. Am J Dermatopathol. 2003;25:223-238.
22. Jafarian F, Powell J, Kokta V, et al. Malignant melanoma in childhood and adolescence: report of 13 cases. J Am Acad Dermatol. 2005;53:816-822.
23. Jen M, Murphy M, Grant-Kels JM. Childhood melanoma. Clin Dermatol. 2009;27:529-536.
24. Strouse JJ, Fears TR, Tucker MA, et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23:4735-4741.
25. Pappo AS. Melanoma in children and adolescents. Eur J Cancer. 2003;39:2651-2661.
26. Paradela S, Fonseca E, Pita-Fernandez S, et al. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 patients. Cancer. 2010;116:4334-4344.
27. Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009;33:1146-1156.
28. Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012;36: 808-817.
29. Paradela S, Fonseca E, Pita S, et al. Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool. J Cutan Pathol. 2009;36:740-752.
30. Gerami P, Jewell SS, Pouryazdanparast P, et al. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. J Mol Diagn. 2011;13:352-358.
31. Pouryazdanparast P, Cowen DP, Beilfuss BA, et al. Distinctive clinical and histologic features in cutaneous melanoma with copy number gains in 8q24. Am J Surg Pathol. 2012;36:253-264.
32. Pouryazdanparast P, Brenner A, Haghighat Z, et al. The role of 8q24 copy number gains and c-MYC expression in amelanotic cutaneous melanoma. Mod Pathol. 2012;25:1221-1226.
33. Barnhill RL. Childhood melanoma. Semin Diagn Pathol. 1998;15: 189-194.